CHOOSE a program that is convenient for you
ENGAGE with healthcare experts and other People with Parkinson's Disease
LEARN about OFF periods and how INBRIJA may be able to help
Treats OFF periods in adults taking carbidopa/levodopa (CD/LD). INBRIJA doesn’t replace CD/LD.
Don’t use if you have taken a nonselective monoamine oxidase
inhibitor (eg, phenelzine, tranylcypromine) within the last 2 weeks.
INBRIJA is a prescription medicine used for the return of Parkinson’s symptoms (known as OFF episodes) in adults treated with carbidopa-levodopa medicines. INBRIJA does not replace regular carbidopa-levodopa medicines.
Do not use INBRIJA if you take or have taken a nonselective monoamine oxidase inhibitor such as phenelzine or tranylcypromine within the last 2 weeks.
Before using INBRIJA, tell your healthcare provider about all your medical conditions, including:
Tell your healthcare provider if you take:
Do not take more than 1 dose (2 capsules) for any OFF period. Do not take more than 5 doses (10 capsules) of INBRIJA in a day.
INBRIJA is for oral inhalation only. Do not swallow or open INBRIJA capsules.
Do not drive, operate machinery, or do other activities until you know how INBRIJA affects you. Sleepiness and falling asleep suddenly can happen as late as a year after treatment is started.
INBRIJA can cause serious side effects including the following. Tell your healthcare provider if you experience them:
The most common side effects of INBRIJA include cough, upper respiratory tract infection, nausea, and change in the color of saliva or spit.
Please see the Patient Information Leaflet.
Many people are being asked to stay home to slow the spread of COVID-19. INBRIJA® (levodopa inhalation powder) continues to be delivered directly to patients' residences, so you can still receive your medication even if you are homebound for a prolonged period of time.
Prescription Support Services is fully functional and remains available to help you with access, reimbursement, and assistance for INBRIJA. At any time, if you have questions, please contact Prescription Support Services at 1‑888‑887‑3447. Prescription Support Services specialists are available to assist you Monday through Friday from 8 AM to 8 PM eastern time. Also, please visit us online at INBRIJA.com/prescription‑support‑services.
If you have questions or concerns about your treatment plan, please consult your doctor.
If you have questions or concerns related to INBRIJA, please feel free to reach out to us at 1‑800‑367‑5109 or firstname.lastname@example.org.